MY
Noveris Health Sciences Inc.
MYCOF · OTC
$0.80 +9.59% (+$0.07)
Market Cap $66.8M
P/E Ratio 40.88x
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
1 /100
Expensive P/E 40.88x
EV/EBITDA 30.87x
P/S N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
79 /100
Excellent ROIC 49.67%
Asset turnover 0.00x
ROA 165.32%
Debt
79 /100
Low Current ratio 0.31x
Net debt/EBITDA -0.20x
Int. coverage 46.96x
Stability
50 /100
Moderate Beta -5.44x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MYCOF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Jason Birmingham
Employees
3
Headquarters
Vancouver
Upcoming events
17 NOV
Earnings
Upcoming earnings report